![](https://static.biospace.com/dims4/default/7ba4027/2147483647/strip/true/crop/622x350+1+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F40C2FF81-A71D-4C91-9018-FCDCDD594B22.jpg)
Despite Near 30% Drop in Humira Sales, AbbVie Beats Wall Street’s Q2 Revenue Expectations
AbbVie announced in its second-quarter 2024 earnings on Thursday that sales of its immunology drugs Rinvoq and Skyrizi rose substantially, while sales of the arthritis drug Humira continued its decline but still exceeded analyst estimates. According to an …